Gynecology : BC Cancer Agency

Agency Links:

Home

Help

Site Map

BC Cancer Agency >> Health Professionals Info >> Chemotherapy Protocols >> Gynecology


Chemotherapy Protocols
	Gynecology

Gynecology

Print this Page

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use available at www.bccancer.bc.ca/legal.htm.

See Ovarian treatments
See Cervical treatments
See Endometrial treatments
See Other treatments

Please note: All links in the tables below open PDF documents.

Ovarian Treatments
Protocol Code and Description	Available documents (revision date indicated in red)
GOBEP: Therapy of non-dysgerminomatous ovarian germ cell cancer using Bleomycin, Etoposide and Cisplatin.	- Protocol (01 May 2009) - Preprinted Order (18 Mar 2010)
GOEP: Therapy of Dysgerminomatous Ovarian Germ Cell Cancer Using Cisplatin and Etoposide.	- Protocol (01 May 2009) - Preprinted Order (01 May 2009)
GOOVCADM: Primary Treatment of Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer, with no Visible Residual Tumour (Moderate-High Risk) Using Carboplatin and Docetaxel.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOOVCADR: Second Line Treatment Using Docetaxel and Carboplatin for Epithelial Ovarian Cancer Relapsing after Primary Treatment.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOOVCADX: Primary Treatment of Visible Residual (Extreme Risk) Invasive Epithelial Ovarian Cancer Using Carboplatin and Docetaxel.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOOVCAG: Treatment of Advanced Ovarian Cancer in Patients Who Have Progressed or Recurred Following First-line Platinum-based Treatment Using Carboplatin and Gemcitabine.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOOVCARB: First or Second Line Therapy for Invasive Epithelial Ovarian Cancer using Single-Agent Carboplatin.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOOVCATM: Primary treatment of invasive epithelial ovarian, fallopian tube and primary peritoneal cancer, with no visible residual tumour (moderate-high risk) using Carboplatin and Paclitaxel.	- Protocol (01 Mar 2010) - Preprinted order (01 May 2009)
GOOVCATR: Second line treatment using paclitaxel and carboplatin for epithelial ovarian cancer relapsing after primary treatment.	- Protocol (01 Mar 2010) - Preprinted order (01 May 2009)
GOOVCATX: Primary treatment of visible residual (extreme risk) invasive epithelial ovarian cancer in ambulatory care settings using Paclitaxel and Carboplatin.	- Protocol (01 Mar 2010) - Preprinted order (01 May 2009)
GOOVCIS: Therapy for Invasive Epithelial Ovarian Cancer using Cisplatin	- Protocol (01 Mar 2010) - Preprinted order (01 Mar 2010) - Patient handout (01 Mar 2010)
GOOVDOC: Treatment Of Progressive, Platinum-Refractory Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma Or Fallopian Tube Carcinoma Using Docetaxel.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOOVETO: Treatment of Relapsed/Progressing Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Etoposide	- Protocol (08 May 2009) - Preprinted order (01 May 2009)
GOOVGEM: Palliative chemotherapy for re-treatment of ovarian, tubal, and peritoneal cancer using gemcitabine.	- Protocol (01 May 2009) - Preprinted order (01 Aug 2009)
GOOVIPPC: BCCA Protocol Summary for Primary Treatment of Stage III less than or equal to 1 cm Visible Residual Invasive Epithelial Ovarian Cancer Using Intravenous and Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin	- Protocol (01 May 2009) - Preprinted order (01 Nov 2009) - Patient handout (01 Oct 2007)
GOOVLDOX: Treatment of Relapsed/Progressing, Epithelial Ovarian, Primary Peritoneal Or Fallopian Tube Carcinoma Using Pegylated Liposomal Doxorubicin	- Protocol (01 Dec 2009) - Preprinted order (01 Mar 2010) - Patient handout (01 Aug 2007)
UGOOVPLDC: Second line treatment for Epithelial Ovarian Cancer Relapsing after primary treatment using Pegylated Liposomal Doxorubicin (PLD) and Carboplatin	- Protocol (01 Nov 2009) - Preprinted order (01 Mar 2010) - Patient Handout (01 Nov 2009)
GOOVTAX3: Treatment of progressive, platinum-refractory epithelial ovarian carcinoma, primary peritoneal carcinoma or fallopian tube carcinoma using paclitaxel.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOOVTOP: Treatment of relapsed/progressive epithelial ovarian, fallopian tube or primary peritoneal cancer using Topotecan.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOOVVIN: Palliative Chemotherapy for Re-treatment of Ovarian, Tubal, and Peritoneal Cancer Using Vinorelbine.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)

Cervical Treatments
Protocol Code and Description	Available Documents (revision date indicated in red)
GOCXCAD: Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with Carboplatin and Docetaxel in Ambulatory Care Settings.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOCXCAT: Primary Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with Carboplatin and Paclitaxel in Ambulatory Care Settings.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOCXCRT (formerly GOCXRADC): Treatment of High Risk Squamous Carcinoma, Adenocarcinoma, or Adenosquamous Carcinoma of the Cervix with Concurrent Cisplatin and Radiation.	- Protocol (01 Mar 2010) - Preprinted order (1 Sep 2009)

Endometrial Treatments
Protocol Code and Description	Available documents (revision date indicated in red
GOENDCAD: Treatment of Primarily Advanced or Recurrent Endometrial Cancer using Carboplatin and Docetaxel.	- Protocol (01 May 2009) - Preprinted order (01 May 2009)
GOENDCAT: Treatment of Primary Advanced or Recurrent Endometrial Cancer using Carboplatin and Paclitaxel	- Protocol (18 Mar 2010) - Preprinted order (01 May 2009)

Others
Protocol Code and Description	Available documents (revision date indicated in red
GOSADG: Treatment of Uterine Sarcoma Cancer using Docetaxel and Gemcitabine	- Protocol (01 Jan 2010) - Preprinted order (01Jan 2010)
GOSMCCRT (formerly GOSMCC2): Treatment of Small Cell or Neuroendocrine Carcinoma of Gynecologic System Origin using Paclitaxel, Cisplatin, Etoposide and Carboplatin with Radiation	- Protocol (01 May 2009) - GOSMCCRT(c) Preprinted order (01 May 2009) - GOSMCCRT(d) Preprinted order (01 May 2009) - GOSMCCRT(e) Preprinted order (01 May 2009)
GOTDHR: Therapy for high risk gestational trophoblastic (GO9103) "MACE" using Cisplatin, Etoposide, Actinomycin D. Methotrexate and Leucovorin.	- Protocol (01 May 2009)
GOTDLR: Therapy for low risk gestational trophoblastic neoplasia (GO 94 02) using Methotrexate, Leucovorin and Actinomycin D.	- Protocol (01 May 2009)

Print this Page

The BC Cancer Agency is a part of the Provincial Health Services Authority .

Unofficial document if printed. Please refer to the following web address for up-to-date information: http://www.bccancer.bc.ca/HPI/ChemotherapyProtocols/Gynecology/default.htm